Clinical trials
Lymphoma, Large-Cell, Anaplastic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
| Completed | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Cancer Group, China | 3 |
| Ruijin Hospital | 2 |
| BeiGene | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
| Immune Cell, Inc. | 1 |
| Jun Zhu | 1 |
| Peking University | 1 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large-Cell, Anaplastic | 19 |
| Immunoblastic Lymphadenopathy | 7 |
| Hodgkin Disease | 6 |
| Lymphoma | 5 |
| Lymphoma, T-Cell, Peripheral | 5 |
| Recurrence | 5 |
| Lymphoma, Extranodal NK-T-Cell | 4 |
| Lymphoma, T-Cell | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.